Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
30,146 total articles
Joby Aviation's stock rose after the company completed New York City's first point-to-point electric vertical takeoff and landing demonstration flights, connecting Manhattan heliports and John F. Kennedy International Airport in under 10 minutes. The flights form part of a federal eVTOL Integration Pilot Program and build on Joby's acquisition of B…
Peloton Interactive's stock rose about 6% after Spotify announced a partnership that gives Premium users in supported markets access to more than 1,400 ad-free Peloton on-demand classes. The move places Peloton content inside Spotify's expanding fitness offering and enables Premium users to stream and download a wide range of workouts across device…
Samsung Electronics is planning to halt sales of televisions and home appliances in China before year-end, with a final decision possibly coming as soon as the end of April. The company would maintain local production of refrigerators, washing machines and air conditioners in China to serve as manufacturing hubs for overseas shipments. Declining pr…
Nitto Denko reported operating profit of ¥183.6 billion for the fiscal year ended March 2026, a 1% decline from the prior year and marginally under the company forecast. Management cited roughly ¥1.5 billion of special-factor charges. For the year ending March 2027 the firm projects operating profit of ¥193 billion, a 5% increase year-over-year, an…
Mizuho analyst Gregg Moskowitz moved in opposite directions on two major software names, upgrading CrowdStrike to Outperform with a higher price target and downgrading Adobe to Neutral while cutting its target. The decisions reflect contrasting views on each company's ability to leverage AI initiatives and current valuation dynamics.
Medtronic reported that a cyber intrusion last week targeted the network that supports its corporate IT systems. The company said the incident did not affect its medical products, patient safety, manufacturing or distribution, and it does not expect a material impact to its business or financial results. Medtronic has activated its response plans a…
U.S. stock futures showed mixed action Monday morning as traders readied for a congested week of events ranging from geopolitical developments to earnings from large AI-focused cloud providers. By 06:46 ET (10:46 GMT), Dow futures were down 39 points (-0.1%), the S&P 500 was essentially flat, and Nasdaq 100 futures were up 37 points (0.1%). Several…
Medtronic reported that a cyber incident that struck parts of its corporate IT infrastructure last week did not affect its medical devices, patient safety, manufacturing or distribution operations. The company has engaged cybersecurity specialists, activated response plans and does not expect the attack to materially alter its business or financial…
Suja Life, Inc. has begun its initial public offering roadshow after filing a registration statement with the SEC. The company is offering 8,888,889 shares of Class A common stock, with an expected price range of $21.00 to $24.00 per share. Suja Life and a selling stockholder have granted underwriters options to purchase additional shares. Proceeds…
Sagimet Biosciences reported a 30% jump in its stock after announcing plans to begin a U.S. Phase 3 trial of denifanstat in moderate to severe acne in the second half of 2026, contingent on IND clearance. The company also disclosed favourable Phase 3 topline results from its China program, prioritized dermatology in capital allocation, is seeking n…
HawkEye 360 filed papers in the United States indicating it aims to raise as much as $416 million through an initial public offering, pricing 16 million shares between $24 and $26. The filing implies a company valuation of up to $2.42 billion. The Herndon, Virginia firm plans to list on the New York Stock Exchange under the symbol HAWK, with severa…
Bank of America strategists Paul Ciana and Jonathan Hartley caution that the common 'sell in May and go away' rule misses important intra-season patterns. Their analysis of S&P 500 returns since 1928 shows the May-October six-month stretch underperforms November-April on average, but the shortfall is concentrated in August-October. BofA argues inve…
United Airlines CEO Scott Kirby confirmed he reached out to American Airlines in recent weeks to explore a possible combination. American declined to pursue talks. Kirby framed the proposal as a growth-first transaction designed to add unionized jobs, broaden service to smaller and international markets, and scale United’s customer-facing investmen…
HawkEye 360, a Herndon, Virginia-based space analytics firm, has filed for a U.S. initial public offering seeking up to $416 million and targeting a valuation of as much as $2.42 billion. The company plans to offer 16 million shares at $24 to $26 each and to list on the New York Stock Exchange under the symbol HAWK. The move comes as the IPO market…
Veradermics' stock rose 17% after the company disclosed topline results from its Phase 2/3 Study '302' of VDPHL01 for male pattern hair loss. The extended-release oral minoxidil formulation achieved statistically significant improvements in hair counts and patient- and investigator-reported measures versus placebo, with no treatment-related serious…
Oruka Therapeutics' stock climbed sharply after the company reported positive Week 16 results from the EVERLAST-A Phase 2a trial of ORKA-001 in moderate-to-severe plaque psoriasis. The study met its primary endpoint, with a majority of treated patients achieving complete skin clearance and secondary endpoints showing deep clinical responses. Safety…
Intellia Therapeutics reported that its Phase 3 HAELO trial of lonvoguran ziclumeran (lonvo-z) met the primary endpoint and all key secondary endpoints, showing an 87% reduction in hereditary angioedema attacks versus placebo over six months. The single-dose, in vivo gene editing therapy demonstrated favorable safety and tolerability among treated …
Wolfe Research reports that energy stocks found buying support after approaching oversold territory last week. The firm highlights the sector's ability to reclaim the 50-day moving average this week as a key test that will help determine whether the move is a short-lived relief rally or the start of a renewed uptrend. A recent washout left more tha…
Top U.S. independent refiners are anticipated to report materially stronger first-quarter results versus a year earlier as supply constraints from the Middle East conflict lifted diesel and jet fuel margins to multi-year highs. The closure of the Strait of Hormuz after the late-February escalation in the region tightened flows of barrels and refine…
Nissan Motor Co. updated its full-year operating forecast, moving from a projected ¥60 billion loss to an expected ¥50 billion profit for the fiscal year ending March 2026. The company announced the revision after markets closed on April 27, attributing the swing mainly to a reversal of provisions tied to U.S. greenhouse gas regulations, alongside …
Barclays, in its European Tactical Playbook, spots a trio of media-related companies it classifies as 'oversold quality' where current market sentiment and valuation appear disconnected from underlying prospects. Canal+, CTS Eventim and Informa are presented as tactical opportunities with asymmetric upside driven by international growth, potential …
Yardeni Research contends that the market low reached on March 30 represents the floor for U.S. equities this year and restates a year-end S&P 500 objective of 7,700. The firm draws a parallel to the 1956 Suez Crisis, notes continued disruptions around the Strait of Hormuz and highlights a resilient earnings backdrop and improving credit flows as r…
In a turbulent month for markets marked by earnings, geopolitical uncertainty tied to the US/Iran ceasefire, and a re-evaluation of long-term interest rates, an AI-driven selection process delivered exceptional short-term returns. Subscribers to the InvestingPro AI stock lists received April recommendations that produced ten winners up more than 30…
Seaport Therapeutics, a clinical-stage biotechnology company based in Boston, has filed for a U.S. initial public offering that would value the company at $912 million. The firm is proposing to sell 11.8 million shares at $16 to $18 each to raise up to $212.4 million, and plans to list on the Nasdaq Global Market under the symbol SPTX. The filing c…
JPMorgan's equity strategy team, led by Mislav Matejka, is urging investors to treat market weakness tied to the Middle East conflict as a buying opportunity rather than a trigger to turn defensive. The bank highlights constraints on a prolonged military confrontation, a milder wages and inflation backdrop than in 2022, policy rates near historical…
